What does CUSIP 501575104 represent in this 13F holders report?

CUSIP 501575104 is the security identifier for KYMR - Kymera Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KYMR - Kymera Therapeutics, Inc. - Common Stock in Q1 2025?

171 institutional investors reported KYMR - Kymera Therapeutics, Inc. - Common Stock for Q1 2025. Use the holders table for investor-level position and value details.

Kymera Therapeutics, Inc. - Common Stock (KYMR)

CUSIP: 501575104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Common Stock
Shares outstanding: 80,235,145
Total 13F shares: 72,808,716
Share change: +1,093,234
Total reported value: $1,995,263,098
Put/Call ratio: 108%
Price per share: $27.37
Number of holders: 171
Value change: +$5,348,226
Number of buys: 84
Number of sells: 85

Quarterly Holders Quick Answers

What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2025
Previous quarter: Q4 2024

Recent filing periods for CUSIP 501575104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q1 2025

As of 31 Mar 2025, Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by 171 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,808,716 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BVF INC/IL, Atlas Venture Life Science Advisors, LLC, FMR LLC, BlackRock, Inc., and Siren, L.L.C.. This page lists 171 institutional shareholders reporting positions in this security for the Q1 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.